M Caldano

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. doi request reprint Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice
    L F van der Voort
    Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
    Mult Scler 15:212-8. 2009
  2. doi request reprint Lack of interferon-beta bioactivity is associated with the occurrence of relapses in multiple sclerosis
    L F van der Voort
    Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
    Eur J Neurol 16:1049-52. 2009
  3. doi request reprint Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis
    Laura F van der Voort
    Department of Neurology, VU Medical Center, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Arch Neurol 67:402-7. 2010
  4. doi request reprint Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS
    L F van der Voort
    VU Medical Center, Department of Neurology, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Neurology 75:1228-33. 2010

Collaborators

Detail Information

Publications4

  1. doi request reprint Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice
    L F van der Voort
    Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
    Mult Scler 15:212-8. 2009
    ..Unclear is how to apply IFN beta bioactivity measurements (quantification of Myxovirus resistance protein A (MxA) mRNA) in clinical practice...
  2. doi request reprint Lack of interferon-beta bioactivity is associated with the occurrence of relapses in multiple sclerosis
    L F van der Voort
    Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
    Eur J Neurol 16:1049-52. 2009
    ..Although absent IFNbeta bioactivity is associated with NAb and NAb are associated with reduced drug efficacy, the direct relationship between IFNbeta bioactivity and clinical disease activity is largely unknown...
  3. doi request reprint Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis
    Laura F van der Voort
    Department of Neurology, VU Medical Center, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Arch Neurol 67:402-7. 2010
    ..To confirm that neutralizing antibodies (NAb) to interferon beta can persist after therapy withdrawal and to evaluate whether persisting NAb are associated with a worse clinical disease course in multiple sclerosis (MS)...
  4. doi request reprint Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS
    L F van der Voort
    VU Medical Center, Department of Neurology, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Neurology 75:1228-33. 2010
    ..To determine if myxovirus resistance protein A (MxA) mRNA is related to clinical disease activity in multiple sclerosis (MS)...